{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:51:22Z","timestamp":1768279882573,"version":"3.49.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T00:00:00Z","timestamp":1546560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2018.01139","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T04:25:23Z","timestamp":1546575923000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Blocking Thrombin Significantly Ameliorates Experimental Autoimmune Neuritis"],"prefix":"10.3389","volume":"9","author":[{"given":"Efrat","family":"Shavit-Stein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramona","family":"Aronovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantin","family":"Sylantiev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orna","family":"Gera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shany G.","family":"Gofrit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joab","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Dori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/jnnp.2008.158303","article-title":"Diagnosis and treatment in inflammatory neuropathies","volume":"80","author":"Lunn","year":"2009","journal-title":"J Neurol Neurosurg Psychiatr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nrneurol.2015.192","article-title":"Progress in inflammatory neuropathy- the legacy of Dr Jack Griffin","volume":"11","author":"Feldman","year":"2015","journal-title":"Nat Rev Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.mayocp.2016.12.002","article-title":"Guillain-Barr\u00e9 syndrome","volume":"92","author":"Wijdicks","year":"2017","journal-title":"Mayo Clin Proc."},{"key":"B4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat Rev Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/00019052-199910000-00011","article-title":"Treatment of immune-mediated inflammatory neuropathies","volume":"12","author":"Hadden","year":"1999","journal-title":"Curr Opin Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/ilar\/ilt054","article-title":"Animal models of autoimmune neuropathy","volume":"54","author":"Soliven","year":"2014","journal-title":"ILAR J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/01.wco.0000245367.36576.e9","article-title":"Bacterial infections in Guillain-Barre and Fisher syndromes","volume":"19","author":"Yuki","year":"2006","journal-title":"Curr Opin Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ana.410400414","article-title":"Acute motor axonal neuropathy: an antibody-mediated attack on axolemma","volume":"40","author":"Hafer-Macko","year":"1996","journal-title":"Ann Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrneurol.2016.172","article-title":"Guillain\u2013Barr\u00e9 syndrome: a century of progress","volume":"12","author":"Goodfellow","year":"2016","journal-title":"Nat Rev Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/ana.24748","article-title":"Zika virus: an emergent neuropathological agent","volume":"80","author":"White","year":"2016","journal-title":"Ann Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13365-018-0621-9","article-title":"Zika virus outbreak in New Caledonia and Guillain-Barr\u00e9 syndrome: a case-control study","volume":"24","author":"Simon","year":"2018","journal-title":"J Neurovirol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain-Barre syndrome: a systematic review","volume":"130","author":"Hughes","year":"2007","journal-title":"Brain"},{"key":"B15","doi-asserted-by":"publisher","first-page":"CD001446","DOI":"10.1002\/14651858.CD001445","article-title":"Corticosteroids for Guillain-Barr\u00e9 syndrome","volume":"2016","author":"Hughes","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1161\/01.CIR.0000131660.51520.9A","article-title":"Bidirectional relation between inflammation and coagulation","volume":"109","author":"Levi","year":"2004","journal-title":"Circulation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fneur.2017.00138","article-title":"A linear temporal increase in thrombin activity and loss of its receptor in mouse brain following ischemic stroke","volume":"8","author":"Bushi","year":"2017","journal-title":"Front Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/jnr.20270","article-title":"Increased thrombin inhibition in experimental autoimmune encephalomyelitis","volume":"79","author":"Beilin","year":"2005","journal-title":"J Neurosci Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/WNR.0b013e328091c1e6","article-title":"Increased KPI containing amyloid precursor protein in experimental autoimmune encephalomyelitis brains","volume":"18","author":"Beilin","year":"2007","journal-title":"Neuroreport"},{"key":"B20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ana.24078","article-title":"Early detection of thrombin activity in neuroinflammatory disease","volume":"75","author":"Davalos","year":"2014","journal-title":"Ann Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10517-005-0071-2","article-title":"Effect of synthetic peptide thrombin receptor agonist encapsulated in microparticles based on lactic and glycolic acid copolymer on healing of experimental skin wounds in mice","volume":"138","author":"Dugina","year":"2004","journal-title":"Bull Exp Biol Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/jcp.25501","article-title":"Role of thrombin in the pathogenesis of central nervous system inflammatory diseases","volume":"232","author":"Ebrahimi","year":"2017","journal-title":"J Cell Physiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.neuroscience.2016.10.034","article-title":"Thrombin and protein C pathway in peripheral nerve Schwann cells","volume":"339","author":"Gera","year":"2016","journal-title":"Neuroscience"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1089\/neu.2015.4146","article-title":"Minimal traumatic brain injury in mice: protease-activated receptor 1 and thrombin-related changes","volume":"33","author":"Itsekson-Hayosh","year":"2016","journal-title":"J Neurotrauma"},{"key":"B25","doi-asserted-by":"publisher","first-page":"7912","DOI":"10.1038\/srep07912","article-title":"Thrombin induces ischemic LTP, (iLTP): implications for synaptic plasticity in the acute phase of ischemic stroke","volume":"5","author":"Stein","year":"2015","journal-title":"Sci Rep."},{"key":"B26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/(SICI)1097-4695(199606)30:2<255::AID-NEU7>3.0.CO;2-4","article-title":"Prevention of activity-dependent neuronal death: vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombin-inhibiting neurotrophic serpin, protease nexin I","volume":"30","author":"Festoff","year":"1996","journal-title":"J Neurobiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1160\/TH09-12-0848","article-title":"The role of thrombin and protease-activated receptors in pain mechanisms","volume":"103","author":"Garcia","year":"2010","journal-title":"Thromb Haemost."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/brain\/awn005","article-title":"Thrombin receptor PAR-1 on myelin at the node of Ranvier: a new anatomy and physiology of conduction block","volume":"131","author":"Shavit","year":"2008","journal-title":"Brain"},{"key":"B29","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0006-8993(80)90811-2","article-title":"Experimental allergic neuritis in the Lewis rat: characterization of the activity of peripheral myelin and its major basic protein,P2","volume":"184","author":"Kadlubowski","year":"1980","journal-title":"Brain Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0006-8993(80)90071-2","article-title":"Experimental allergic neuritis. I Rat strain differences in the response to bovine myelin antigens","volume":"195","author":"Hoffman","year":"1980","journal-title":"Brain Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jneuroim.2005.07.008","article-title":"Inhibition of Ras attenuates the course of experimental autoimmune neuritis","volume":"168","author":"Kafri","year":"2005","journal-title":"J Neuroimmunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1007\/s10753-012-9447-4","article-title":"Pioglitazone, PPAR\u03b3 agonist, attenuates experimental autoimmune neuritis","volume":"35","author":"Ramkalawan","year":"2012","journal-title":"Inflammation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1006\/jsre.2000.6065","article-title":"A serine protease inhibitor, N-alpha-tosyl-l-lysine chloromethyl ketone, prolongs rat hepatic allograft survival","volume":"96","author":"Zhang","year":"2001","journal-title":"J Surg Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1097\/00001756-200108080-00013","article-title":"Quantitative measurements of mouse brain thrombin-like and thrombin inhibition activities","volume":"12","author":"Beilin","year":"2001","journal-title":"Neuroreport"},{"key":"B35","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/j.1471-4159.2011.07436.x","article-title":"Anatomical localization of protease-activated receptor-1 and protease-mediated neuroglilal crosstalk on peri-synaptic astrocytic endfeet","volume":"119","author":"Shavit","year":"2011","journal-title":"J Neurochem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/mus.10011","article-title":"Assessment of experimental autoimmune neuritis in the rat by electrophysiology of the tail nerve","volume":"25","author":"Kafri","year":"2002","journal-title":"Muscle Nerve"},{"key":"B37","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/mus.21588","article-title":"Dorsal caudal tail and sciatic motor nerve conduction studies in adult mice: technical aspects and normative data","volume":"41","author":"Xia","year":"2010","journal-title":"Muscle Nerve"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"key":"B39","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1046\/j.0022-3042.2001.00745.x","article-title":"Participation of protease-activated receptor-1 in thrombin-induced microglial activation","volume":"80","author":"Suo","year":"2002","journal-title":"J Neurochem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/ijms17010084","article-title":"The importance of thrombin in cerebral injury and disease","volume":"17","author":"Krenzlin","year":"2016","journal-title":"Int J Mol Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.bbrc.2007.10.002","article-title":"Thrombin regulates the function of human blood dendritic cells","volume":"364","author":"Yanagita","year":"2007","journal-title":"Biochem Biophys Res Commun."},{"key":"B42","first-page":"6","article-title":"Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","volume-title":"Cochrane Database of Systematic Reviews","author":"Hughes","year":"2014"},{"key":"B43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/14651858.CD001798.pub3","article-title":"Plasma exchange for Guillain-Barr\u00e9 syndrome","volume":"2017","author":"Chevret","year":"2017","journal-title":"Cochrane Database Syst Rev."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2018.01139\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T04:25:25Z","timestamp":1546575925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2018.01139\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,4]]},"references-count":43,"alternative-id":["10.3389\/fneur.2018.01139"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2018.01139","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,4]]},"article-number":"1139"}}